SG55583G - N-aminoalkyl-heterocycles,methods for their preparation and compositions containing them - Google Patents

N-aminoalkyl-heterocycles,methods for their preparation and compositions containing them

Info

Publication number
SG55583G
SG55583G SG555/83A SG55583A SG55583G SG 55583 G SG55583 G SG 55583G SG 555/83 A SG555/83 A SG 555/83A SG 55583 A SG55583 A SG 55583A SG 55583 G SG55583 G SG 55583G
Authority
SG
Singapore
Prior art keywords
aminoalkyl
heterocycles
preparation
methods
compositions containing
Prior art date
Application number
SG555/83A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG55583G publication Critical patent/SG55583G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/36One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
SG555/83A 1976-03-09 1983-09-01 N-aminoalkyl-heterocycles,methods for their preparation and compositions containing them SG55583G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (1)

Publication Number Publication Date
SG55583G true SG55583G (en) 1984-07-27

Family

ID=5971857

Family Applications (1)

Application Number Title Priority Date Filing Date
SG555/83A SG55583G (en) 1976-03-09 1983-09-01 N-aminoalkyl-heterocycles,methods for their preparation and compositions containing them

Country Status (36)

Country Link
US (4) US4154829A (fr)
JP (2) JPS52108970A (fr)
AT (1) AT360542B (fr)
AU (1) AU515953B2 (fr)
BE (1) BE852223A (fr)
BG (4) BG28052A4 (fr)
CA (1) CA1086317A (fr)
CH (8) CH630358A5 (fr)
CS (2) CS209435B2 (fr)
DD (1) DD130037A5 (fr)
DE (1) DE2609645A1 (fr)
DK (1) DK102177A (fr)
ES (10) ES456622A1 (fr)
FI (1) FI69070C (fr)
FR (2) FR2343731A1 (fr)
GB (1) GB1571231A (fr)
GR (1) GR64553B (fr)
HK (1) HK12884A (fr)
HU (1) HU177953B (fr)
IE (1) IE45300B1 (fr)
IL (1) IL51627A (fr)
LU (1) LU76898A1 (fr)
MX (1) MX4878E (fr)
MY (1) MY8500079A (fr)
NL (1) NL7702403A (fr)
NO (1) NO147950C (fr)
NZ (1) NZ183536A (fr)
PH (3) PH16110A (fr)
PL (2) PL111240B1 (fr)
PT (1) PT66282B (fr)
RO (3) RO70569A (fr)
SE (1) SE435059B (fr)
SG (1) SG55583G (fr)
SU (4) SU698530A3 (fr)
YU (1) YU62377A (fr)
ZA (1) ZA771412B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
BE883068A (fr) 1979-05-04 1980-08-18 Continental Pharma Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (fr) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
DE69711519T2 (de) 1996-09-05 2002-10-31 Eli Lilly And Co., Indianapolis Carbazolanaloge als selektive beta3-adrenergische Agonisten
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
HUP0402510A3 (en) 2001-04-18 2012-08-28 Euro Celtique Sa Nociceptin analogs and pharmaceutical compositions containing them
DE60229736D1 (de) 2001-04-18 2008-12-18 Euro Celtique Sa Spiroinden- und spiroindan-verbindungen
BR0209127A (pt) 2001-04-18 2006-03-21 Euro Celtique Sa compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
US6872733B2 (en) * 2001-04-18 2005-03-29 Euro-Celtique S.A. Benzimidazolone compounds
AU2002307416B2 (en) * 2001-04-18 2005-08-11 Euro-Celtique S.A. Nociceptin analogs
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
JP2006509790A (ja) * 2002-11-27 2006-03-23 アルテシアン セラピューティック,インコーポレイティド 心不全の治療のための混合されたPDE阻害およびβアドレナリン拮抗薬活性または部分的作用薬活性を有する化合物
US20070117978A1 (en) * 2002-12-23 2007-05-24 Artesian Therapecutics, Inc Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
WO2006060127A2 (fr) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Composes a activite a la fois inhibitrice de la pde et antagoniste ou agoniste partielle des recepteurs $g(b)-adrenergiques pour le traitement de l'insuffisance cardiaque
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
CN101208316B (zh) * 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2642239A1 (fr) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Combinaisons medicamenteuses pour le traitement de pathologies des voies respiratoires
PE20080142A1 (es) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
EP2051714B1 (fr) 2006-08-07 2011-04-13 Boehringer Ingelheim International GmbH Combinaisons de médicaments pour le traitement des infections des voies respiratoires
US8809381B2 (en) * 2007-08-16 2014-08-19 The University Of Mississippi Highly selective sigma receptor ligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (fr) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (fr) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (fr) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
US4363814A (en) 1982-12-14
DE2609645A1 (de) 1977-09-15
PH16149A (en) 1983-07-12
HK12884A (en) 1984-02-24
ES466602A1 (es) 1978-10-01
CH630363A5 (de) 1982-06-15
JPS6172A (ja) 1986-01-06
BG28053A4 (en) 1980-02-25
LU76898A1 (fr) 1978-06-01
AT360542B (de) 1981-01-12
CA1086317A (fr) 1980-09-23
CS220320B2 (en) 1983-03-25
ES466601A1 (es) 1978-10-01
NL7702403A (nl) 1977-09-13
GR64553B (en) 1980-04-14
US4271158A (en) 1981-06-02
US4215119A (en) 1980-07-29
IL51627A (en) 1980-10-26
ES456622A1 (es) 1978-03-16
SU698530A3 (ru) 1979-11-15
PL111240B1 (en) 1980-08-30
RO79706A (fr) 1982-08-17
YU62377A (en) 1982-10-31
JPS52108970A (en) 1977-09-12
ES466604A1 (es) 1978-10-01
PT66282B (pt) 1979-01-17
GB1571231A (en) 1980-07-09
AU515953B2 (en) 1981-05-14
NO147950C (no) 1983-07-13
DK102177A (da) 1977-09-10
ES466603A1 (es) 1978-10-01
IL51627A0 (en) 1977-05-31
BG27743A3 (en) 1979-12-12
AU2300977A (en) 1978-09-14
IE45300B1 (en) 1982-07-28
PT66282A (pt) 1977-04-01
FR2343731B1 (fr) 1982-02-26
PH16110A (en) 1983-06-30
BE852223A (fr) 1977-09-08
FR2372810B1 (fr) 1982-11-26
CH630360A5 (de) 1982-06-15
PH17635A (en) 1984-10-18
CS209435B2 (en) 1981-12-31
NO147950B (no) 1983-04-05
SE7702609L (sv) 1977-10-11
SU683616A3 (ru) 1979-08-30
RO70569A (fr) 1981-11-24
FI69070C (fi) 1985-12-10
IE45300L (en) 1977-09-09
ES466598A1 (es) 1978-10-01
ES466606A1 (es) 1978-10-01
FI770586A (fr) 1977-09-10
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
ES466600A1 (es) 1978-10-01
BG28051A4 (en) 1980-02-25
NZ183536A (en) 1981-11-19
ATA122377A (de) 1980-06-15
MY8500079A (en) 1985-12-31
BG28052A4 (en) 1980-02-25
US4154829A (en) 1979-05-15
SE435059B (sv) 1984-09-03
CH630361A5 (de) 1982-06-15
HU177953B (en) 1982-02-28
FI69070B (fi) 1985-08-30
CH630358A5 (de) 1982-06-15
PL112937B1 (en) 1980-11-29
CH630359A5 (de) 1982-06-15
SU685149A3 (ru) 1979-09-05
FR2372810A1 (fr) 1978-06-30
NO770804L (no) 1977-09-12
ES466599A1 (es) 1978-10-01
CH630362A5 (de) 1982-06-15
CH630365A5 (de) 1982-06-15
ZA771412B (en) 1978-11-29
PL196505A1 (pl) 1979-06-18
RO76589A (fr) 1981-04-30
CH630364A5 (de) 1982-06-15
DD130037A5 (de) 1978-03-01
FR2343731A1 (fr) 1977-10-07
ES466605A1 (es) 1978-10-01

Similar Documents

Publication Publication Date Title
SG55583G (en) N-aminoalkyl-heterocycles,methods for their preparation and compositions containing them
DE2861316D1 (en) Thienothiazine derivatives, their preparation and compositions containing them
IL52131A (en) Substituted 4-amino-4-arylcyclohexanones and their ketals,their preparation and pharmaceutical compositions containing them
IL53063A (en) Phenoxy-amino-propanols,processes for their preparation and pharmaceutical compositions comprising them
JPS5325489A (en) Phhindicating composition and process for its preparation
IL51463A (en) Insecticidal compositions containing n-benzyl-n-methyl-2-propynylamine derivatives,several novel n-benzyl-n-methyl-2-propynylamine derivatives and their preparation
IL51076A (en) Glucosamine-3-alkanoyl-dipeptides, their manufacture and ppharmaceutical compositions containing them
IL51865A0 (en) New fluoroacylresorcin derivatives their preparation and compositions containing them
IL51322A (en) Hypolipidaemic compositions containing aralkylanilines,certain such new aralkyl-analines and their preparation
IL48905A0 (en) New oxadiazolinone derivatives,their preparation and pesticidal compositions containing them
ZA774479B (en) Peptides,processes for their preparation and compositions containing same
DE2860942D1 (en) Indanamines, processes for their preparation and compositions containing them
MY8000099A (en) Isobutyramides, their preparation and therapeutic compositions containing them
IL51877A0 (en) Omega-nor-aromatic-13,14-dehydro-prostaglandins and process for their preparation
IL52137A (en) N-heterocyclic-n-(hetero)arylfluoroalkylamines,their preparation and pharmaceutical compositions containing them
IL55315A0 (en) New 4-hydroxy-2-benzimidazolinone derivatives,processes for the preparation thereof and pahrmaceutical compositions containing the same
DE2860370D1 (en) Isopenicillins, processes for their preparation, and compositions containing them
IL52148A (en) Substituted 1-phenoxy-2-hydroxy-3-aminopropanes,process for preparing same and pharmaceutical compositions containing them
DE2860313D1 (en) Compositions containing aminoalkoxyamines, and processes for their preparation
EP0002939A3 (en) Novel carbothioamides, compositions containing them, their preparation and use
GB1531301A (en) N-aralkyl-2-amino-propanamides methods for their preparation and compositions containing them
IL52165A (en) 2-cyano-2-oximinoacetamide derivatives, their preparation and fungicidal compositions containing them
IL52207A (en) Substituted 2-vinyl-chromones, process for their preparation and pharmaceutical compositions containing them
DE2860861D1 (en) Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them
IL55460A (en) 2-guanidinomethyl-indolines,processes for their preparation and pharmalceutical compositions comprising them